Search Results

There are 9656 results for: content related to: A methamphetamine analog ( N,α -diethyl-phenylethylamine) identified in a mainstream dietary supplement

  1. Quantification of aconitine in post-mortem specimens by validated liquid chromatography-tandem mass spectrometry method: Three case reports on fatal ‘monkshood’ poisoning

    Drug Testing and Analysis

    Volume 5, Issue 9-10, September-October 2013, Pages: 753–762, Wolfgang Bicker, Fabio Monticelli, Andreas Bauer, Gabriele Roider and Thomas Keller

    Article first published online : 10 JUN 2013, DOI: 10.1002/dta.1501

  2. Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases

    Drug Testing and Analysis

    Volume 6, Issue 6, June 2014, Pages: 542–551, Nilusha L.T. Padivitage, Edra Dodbiba, Zachary S. Breitbach and Daniel W. Armstrong

    Article first published online : 20 SEP 2013, DOI: 10.1002/dta.1534

  3. Identification of (2-aminopropyl)indole positional isomers in forensic samples

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 598–606, Kenneth R. Scott, John D. Power, Seán D. McDermott, John E. O'Brien, Brian N. Talbot, Michael G. Barry and Pierce V. Kavanagh

    Article first published online : 8 JUL 2013, DOI: 10.1002/dta.1508

  4. The in vivo and in vitro metabolism and the detectability in urine of 3’,4’-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MSn

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 746–756, Markus R. Meyer, Sandra Mauer, Golo M. J. Meyer, Julia Dinger, Birgit Klein, Folker Westphal and Hans H. Maurer

    Article first published online : 7 OCT 2013, DOI: 10.1002/dta.1559

  5. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 17–23, Ulrike Thieme, Gustav Schelling, Daniela Hauer, Robert Greif, Torsten Dame, Ruediger Paul Laubender, Werner Bernhard, Detlef Thieme, Patrizia Campolongo and Lorenz Theiler

    Article first published online : 28 OCT 2013, DOI: 10.1002/dta.1561

  6. Comparison of drug concentrations between whole blood and oral fluid

    Drug Testing and Analysis

    Volume 6, Issue 5, May 2014, Pages: 461–471, Kaarina Langel, Hallvard Gjerde, Donata Favretto, Pirjo Lillsunde, Elisabeth Leere Øiestad, Santo Davide Ferrara and Alain G. Verstraete

    Article first published online : 9 SEP 2013, DOI: 10.1002/dta.1532

  7. Monitoring the endogenous steroid profile disruption in urine and blood upon nandrolone administration: An efficient and innovative strategy to screen for nandrolone abuse in entire male horses

    Drug Testing and Analysis

    Volume 6, Issue 4, April 2014, Pages: 376–388, Z. Kaabia, G. Dervilly-Pinel, M.A. Popot, L. Bailly-Chouriberry, P. Plou, Y. Bonnaire and B. Le Bizec

    Article first published online : 15 AUG 2013, DOI: 10.1002/dta.1520

  8. Screening of testosterone esters in human plasma

    Drug Testing and Analysis

    Volume 5, Issue 11-12, November-December 2013, Pages: 826–833, G. Forsdahl, H.K. Vatne, T. Geisendorfer and G. Gmeiner

    Article first published online : 7 OCT 2013, DOI: 10.1002/dta.1560

  9. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls

    Drug Testing and Analysis

    Volume 3, Issue 9, September 2011, Pages: 609–620, Ines Möller, Annette Wintermeyer, Katja Bender, Martin Jübner, Andreas Thomas, Oliver Krug, Wilhelm Schänzer and Mario Thevis

    Article first published online : 24 SEP 2010, DOI: 10.1002/dta.158

  10. New phenethylamines in Europe

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 808–818, L. A. King

    Article first published online : 5 NOV 2013, DOI: 10.1002/dta.1570

  11. Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine

    Drug Testing and Analysis

    Volume 6, Issue 6, June 2014, Pages: 506–515, E. L. Menzies, S. C. Hudson, P. I. Dargan, M. C. Parkin, D. M. Wood and A. T. Kicman

    Article first published online : 5 NOV 2013, DOI: 10.1002/dta.1541

  12. THCCOOH concentrations in whole blood: Are they useful in discriminating occasional from heavy smokers?

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 155–163, Marie Fabritius, Bernard Favrat, Haithem Chtioui, Giovanni Battistella, Jean-Marie Annoni, Monique Appenzeller, Kim Dao, Eleonora Fornari, Estelle Lauer, Jean-Frédéric Mall, Philippe Maeder, Patrice Mangin, Christian Staub and Christian Giroud

    Article first published online : 31 OCT 2013, DOI: 10.1002/dta.1581

  13. Drug-drug interaction and doping, part 1: An in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of toremifene

    Drug Testing and Analysis

    Volume 6, Issue 5, May 2014, Pages: 482–491, Monica Mazzarino, Xavier de la Torre, Ilaria Fiacco, Amelia Palermo and Francesco Botrè

    Article first published online : 15 JAN 2014, DOI: 10.1002/dta.1592

  14. Differences in sialic acid O-acetylation between human urinary and recombinant erythropoietins: a possible mass spectrometric marker for doping control

    Drug Testing and Analysis

    Volume 5, Issue 11-12, November-December 2013, Pages: 877–889, Christian Reichel

    Article first published online : 6 NOV 2013, DOI: 10.1002/dta.1563

  15. Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 7–16, Natalia Battista, Manuel Sergi, Camilla Montesano, Sabino Napoletano, Dario Compagnone and Mauro Maccarrone

    Article first published online : 11 NOV 2013, DOI: 10.1002/dta.1574

  16. A high throughput screen for 17 Dermorphin peptides in equine and human urine and equine plasma

    Drug Testing and Analysis

    Volume 6, Issue 9, September 2014, Pages: 909–921, Rohan Steel, Mark Timms, Vita Levina and John Vine

    Article first published online : 20 NOV 2013, DOI: 10.1002/dta.1585

  17. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing

    Drug Testing and Analysis

    Volume 5, Issue 11-12, November-December 2013, Pages: 810–818, Wilhelm Schänzer, Sven Guddat, Andreas Thomas, Georg Opfermann, Hans Geyer and Mario Thevis

    Article first published online : 19 JUL 2013, DOI: 10.1002/dta.1516

  18. Simultaneous quantification of acetaminophen and structurally related compounds in human serum and plasma

    Drug Testing and Analysis

    Volume 6, Issue 5, May 2014, Pages: 451–460, Caroline Bylda, Roland Thiele, Uwe Kobold and Dietrich A. Volmer

    Article first published online : 2 SEP 2013, DOI: 10.1002/dta.1527

  19. Metabolism of boldione in humans by mass spectrometric techniques: detection of pseudoendogenous metabolites

    Drug Testing and Analysis

    Volume 5, Issue 11-12, November-December 2013, Pages: 834–842, Xavier de la Torre, Davide Curcio, Cristiana Colamonici, Francesco Molaioni and Francesco Botrè

    Article first published online : 20 NOV 2013, DOI: 10.1002/dta.1567

  20. DART-MS for rapid, preliminary screening of urine for DMAA

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 788–796, Ashton D. Lesiak, Kendra J. Adams, Marek A. Domin, Colin Henck and Jason R. E. Shepard

    Article first published online : 25 OCT 2013, DOI: 10.1002/dta.1540